Explore
Premium
Sign Up
Log In
CRT 2017 : Optimization of Anticoagulation for STEMI Therapy - Supported by educational grants from AstraZenca, Chiesi USA, Inc. and Medicure, Inc.
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$16.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
Optimization of Anticoagulation for STEMI Therapy - Supported by educational grants from AstraZenca, Chiesi USA, Inc. and Medicure, Inc.
Featuring
Kyle Buchanan
Paul Gurbel
Michael Lipinski
M Chadi Alraies
A. Michael Lincoff
Gary Schaer
David Cohen
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$16.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Case Presentation - Kyle Buchanan
Is There Such a Thing as Adequate P2Y12 Pretreatment for ACS?: Contemporary Use of IV Antiplatelet Agents - Paul Gurbel
Maintaining Ischemic Protection While Improving Safety Outcomes: Can We Standardize Short Infusion Glycoprotein IIb/IIIa Inhibitor Use? - Michael Lipinski
Antiplatelet Options in the Cathlab: How Can We Find Value? - Michael Lipinski
Case Presentation - M Chadi Alraies
Should We Preload STEMI Patients With Antiplatelet Therapy? - A. Michael Lincoff
Antiplatelet Therapy for STEMI: The Case for Cangrelor - Gary Schaer
The Role of Long-Term DAPT after STEMI - David Cohen
Target Audience
Learning Objectives
Related Moments
CardioAlex 2016 - Read with the Experts: CMR Case
Conference
CardioAlex 2016 session on Cardiac Magnetic Resonance
CRT 2017 : BRS TECHNOLOGIES - BRS Show Me the Data: Insights into Variety of BRS Programs
Conference
CRT 2017 : Navigating Changes in LDL Management: Focus on the PCSK9 Inhibitors
Conference
Loading Simple Education